Quoin Pharmaceuticals Ltd DRC (QNRX NASDAQ) stock market data APIs
$11.3743
1.61(14.2%)
as of October 30, 2025
Try our APIs with
free plan!
Quoin Pharmaceuticals Ltd DRC Financial Data Overview
Price chart is built with
Anychart
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Prev. Close
11.3743
Open
12.9883
High
12.9883
Low
10.9849
52 wk Range
5.01-32.095
Market Cap
6 890 K
P/E Ratio
0.0119
Shares Outstanding
603 K
EPS
-219.93
Beta
1.864
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quoin Pharmaceuticals Ltd DRC data using free add-ons & libraries
Get Quoin Pharmaceuticals Ltd DRC Fundamental Data
Quoin Pharmaceuticals Ltd DRC Fundamental data includes:
- Net Revenue:
- EBITDA: -12 583 419
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quoin Pharmaceuticals Ltd DRC News
New
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
ASHBURN, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orpha...
Top Midday Gainers
Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
ASHBURN, Va., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare a...
MSCI Shares Cross Above 200 DMA
In trading on Tuesday, shares of MSCI Inc (Symbol: MSCI) crossed above their 200 day moving average of $513.38, changing hands as high as $520.93 per share. MSCI Inc shares are currently trading up a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
